Simulect

NDC 0078-0393 · Novartis Pharmaceuticals Corporation

Generic namebasiliximab

Dosage formINJECTION, POWDER, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)BASILIXIMAB

Strength10 mg/2.5mL

Pharmacologic classInterleukin 2 Receptor Antagonists [MoA], Interleukin 2 Receptor-directed Antibody Interactions [MoA], Interleukin-2 Receptor Blocking Antibody [EPC]

Marketing categoryBLA

Packages

0078-0393-61 — 1 VIAL, SINGLE-USE in 1 CARTON (0078-0393-61) / 2.5 mL in 1 VIAL, SINGLE-USE

Billed under HCPCS

J0480 — Injection, basiliximab, 20 mg Medicare Part B payment limit (ASP + 6%): $4917.63

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0078-0331 — basiliximab

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources